Jean Volatier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MaaT Pharma Presents the Results of its Annual Ordinary and Extraordinary General Meeting

Regulatory News: MaaT Pharma (EURONEXT: MAAT the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing

Karim dabbaghJean marie lefebvreJean volatierBpifrance investissementNadia kamalKepler cheuvreuxClaude bertrandSenior pr corporate communicationsCompany universal registration documentTrophic communicationsRegulatory newsMicrobiome ecosystemExtraordinary general meetingSeventure partnersChief executive officerAnnual general meeting

Inventiva S A (NASDAQ:IVA) Q4 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Inventiva Annual Results 2023 conference call. At this time, all participants are in a listen-only mode.

South koreaUnited statesSteve harrisonSino biopharmPierre broquaSeamus fernandezJean volatierEuropean investment bankValuerich incQatar holdingUniversity of floridaCall transcript marchInventiva annual resultsPrivate securities litigation reform actCo founder pierreProfessor cusi

Inventiva announces the schedule of publication and presentation of its 2023 Full-Year Financial Results - Inventiva (OTC:IVEVF), Inventiva (NASDAQ:IVA)

Daix (France), Long Island City (New York, United States), March 22, 2024 – Inventiva (NASDAQ:IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment

United statesNew yorkFrance generalJean volatierPierre broquaLong island cityChief scientific officerChief financial officerEuronext parisNasdaq global market

Inventiva draws down the second tranche of €25 million under existing Finance Contract with the European Investment Bank

Inventiva intends to use the proceeds to fund part of its ongoing pivotal NATiV3 Phase III clinical trial evaluating lanifibranor in patients with.

United statesNew yorkPascaline clercJean volatierAude lepreuxExchange commission onEuropean investment bankPatricial bankCompany natiBrunswick groupCorporate affairsLong island cityEuronext parisFinance contractDeputy chief executive officerChief financial officer

INVENTIVA: Inventiva draws down the second tranche of €25 million under existing Finance Contract with the European Investment Bank

INVENTIVA: Inventiva draws down the second tranche of €25 million under existing Finance Contract with the European Investment Bank
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesNew yorkPascaline clercAude lepreuxJean volatierCorporate affairsExchange commission onCompany natiPatricial bankBrunswick groupEuropean investment bankLong island cityEuronext parisFinance contractDeputy chief executive officerChief financial officer